• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[伴有肝细胞癌的结节内结节的肝胆期图像表现分类及病理特征]

[Hepatobiliary phase image manifestation classification and pathological features of nodules in nodules accompanied by hepatocellular carcinoma].

作者信息

Xing F, Zhu W J, Jiang J F, Lu J, Zhang T, Ma Q R

机构信息

Department of Radiology, the Third Affiliated Nantong Hospital of Nantong University, Nantong226000, China.

Department of Pathology, the Third Affiliated Nantong Hospital of Nantong University, Nantong226000, China.

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2024 Nov 20;32(11):989-996. doi: 10.3760/cma.j.cn501113-20231221-00291.

DOI:10.3760/cma.j.cn501113-20231221-00291
PMID:39623574
Abstract

To analyze the hepatobiliary phase (HBP) image manifestation classification and pathological features of nodules in nodules accompanied by hepatocellular carcinoma (NIN-HCC). Twenty-five cases cases (27 lesions) with cirrhosis who were confirmed as NIN-HCC by surgical pathology and underwent gadoxetate disodium-enhanced MRI examination before surgery at Nantong Third Hospital affiliated with Nantong University from July 2015 to November 2022 were retrospectively enrolled. The size, signal intensity, enhancement pattern, and pathological features of internal and external nodules were analyzed in NIN-HCC. The lesions score were recorded according to the 2018 version of the Liver Imaging Reporting and Data Systems (LI-RADS) classification criteria. NIN-HCCs were grouped and typed according to the different HBP signal intensities of the inner and outer nodules. The independent-samples -test, Mann-Whitney test or Fisher's exact probability method were used to compare the differences in imaging features and LI-RADS scores between the groups. The Spearman correlation coefficient was used to evaluate the correlation between the pathological differentiation degree of internal and external nodules and the HBP signal intensity. The Kaplan-Meier curve was used to analyze recurrence-free survival (RFS) following NIN-HCC surgery. The internal nodules of the 27 NIN-HCCs showed altered hypervascularity with a maximum diameter of (13.2±5.5) mm during the arterial phase. 51.9% (14/27) and 48.1% (13/27) showed "fast in and fast out" and fast in and slow out"enhancement patterns. The external nodules showed altered hypovascularity with a maximum diameter of (25.7±7.3) mm, and 13 (48.1%) of them were accompanied to manifest during the arterial phase. NIN-HCC was divided into two groups according to the signal intensity of HBP of the outer nodules with the background liver parenchyma signal intensity as a reference: the hyposignal group (=17, 63.0%) and the isosignal group (=10, 37.0%). The hyposignal group and the isosignal group were divided into AC type and DF type, a total of six types, according to the hypo, iso, and hyper signals of the inner nodules and the signal intensity of the outer nodules as a reference. Within the hyposignal group, 7.4% (2/27) of the inner nodules showed hyposignal (type A), 37.0% (10/27) showed isosignal (type B), and 18.5% (5/27) showed hypersignal (type C). Within the isosignal group, 29.6% (8/27) of the inner nodules showed hyposignal (type D), 7.4% (2/27) showed isosignal (type E), and there was no hypersignal (type F). 40.7% (11/27) of the lesions were LR-4 in LI-RADS score, and 59.3% (16/27) were LR-5. There was no statistically significant difference (>0.05) in the maximum diameter, enhancement pattern, and LI-RADS score of internal and external nodules between the hypo and iso signal group. Histologically, NIN-HCC showed fine trabecular/pseudoglandular duct type without microvascular invasion, among which the inner nodules were mainly moderately differentiated HCC, and the outer nodules were mainly well-differentiated HCC. The degree of differentiation between the inner and outer nodules and the HBP signal intensity had no statistically significant difference (=0.290, =0.143; =0.079, =0.697). The median RFS follow-up time after NIN-HCC radical resection was 31.7 months, and the cumulative RFS rates at 1, 3, and 5 years were 96.0%, 76.0%, and 64.0%, respectively. NIN-HCC can serve as a morphological marker for early-stage diagnosis of multi-step cancer evolution in HCC, with certain imaging and pathological features. HBP imaging classification is helpful to enhance the diagnostic recognition of this disease.

摘要

分析伴肝细胞癌结节内结节(NIN-HCC)的肝胆期(HBP)图像表现分类及病理特征。回顾性纳入2015年7月至2022年11月在南通大学附属南通第三医院手术病理确诊为NIN-HCC且术前接受过钆塞酸二钠增强MRI检查的25例(27个病灶)肝硬化患者。分析NIN-HCC内部及外部结节的大小、信号强度、强化方式及病理特征。根据2018版肝脏影像报告和数据系统(LI-RADS)分类标准记录病灶评分。根据内部及外部结节不同的HBP信号强度对NIN-HCC进行分组及分型。采用独立样本t检验、Mann-Whitney检验或Fisher确切概率法比较组间影像特征及LI-RADS评分差异。采用Spearman相关系数评估内部及外部结节病理分化程度与HBP信号强度的相关性。采用Kaplan-Meier曲线分析NIN-HCC手术后的无复发生存期(RFS)。27个NIN-HCC的内部结节在动脉期表现为高血供改变,最大直径为(13.2±5.5)mm。51.9%(14/27)和48.1%(13/27)表现为“快进快出”和“快进慢出”强化方式。外部结节表现为低血供改变,最大直径为(25.7±7.3)mm,其中13个(48.1%)在动脉期有强化表现。以背景肝实质信号强度为参照,根据外部结节HBP信号强度将NIN-HCC分为两组:低信号组(n = 17,63.0%)和等信号组(n = 10,37.0%)。以内部结节的低、等、高信号及外部结节信号强度为参照,将低信号组和等信号组分为AC型和DF型,共六种类型。在低信号组中,内部结节7.4%(2/27)表现为低信号(A型),37.0%(10/27)表现为等信号(B型),18.5%(5/27)表现为高信号(C型)。在等信号组中,内部结节29.6%(8/27)表现为低信号(D型),7.4%(2/27)表现为等信号(E型),无高信号(F型)。40.7%(11/27)的病灶LI-RADS评分为LR-4,59.3%(16/27)为LR-5。低信号组与等信号组内部及外部结节的最大直径、强化方式及LI-RADS评分差异无统计学意义(P>0.05)。组织学上,NIN-HCC表现为细梁状/假腺管型,无微血管侵犯,其中内部结节主要为中分化HCC,外部结节主要为高分化HCC。内部及外部结节的分化程度与HBP信号强度差异无统计学意义(rs = 0.290,P = 0.143;rs = 0.079,P = 0.697)。NIN-HCC根治性切除术后的中位RFS随访时间为31.7个月,1、3、5年的累积RFS率分别为96.0%、76.0%和64.0%。NIN-HCC可作为HCC多步骤癌变早期诊断的形态学标志物,具有一定的影像及病理特征。HBP影像分类有助于提高对本病的诊断认识。

相似文献

1
[Hepatobiliary phase image manifestation classification and pathological features of nodules in nodules accompanied by hepatocellular carcinoma].[伴有肝细胞癌的结节内结节的肝胆期图像表现分类及病理特征]
Zhonghua Gan Zang Bing Za Zhi. 2024 Nov 20;32(11):989-996. doi: 10.3760/cma.j.cn501113-20231221-00291.
2
Nodule-in-nodule architecture of hepatocellular carcinomas: enhancement patterns in the hepatobiliary phase and pathological features.肝癌的结节内结节样结构:肝胆期强化模式和病理特征。
Abdom Radiol (NY). 2024 Nov;49(11):3834-3846. doi: 10.1007/s00261-024-04259-y. Epub 2024 Jun 24.
3
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.在一项多中心回顾性研究中,1006 个结节的对比超声 LI-RADS LR-5 可识别肝硬化中的肝细胞癌。
J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11.
4
New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS Classification.肝硬化肝脏 MRI 的新动脉期增强结节:向肝细胞癌进展的风险及其对 LI-RADS 分类的影响。
AJR Am J Roentgenol. 2020 Aug;215(2):382-389. doi: 10.2214/AJR.19.22033. Epub 2020 May 20.
5
Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.超声造影肝脏影像报告与数据系统:在肝细胞癌和胆管细胞癌诊断中的优缺点。
World J Gastroenterol. 2022 Jul 21;28(27):3488-3502. doi: 10.3748/wjg.v28.i27.3488.
6
Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma.钆塞酸增强 MRI 的动脉减影图像提高了早期肝细胞癌的诊断准确性。
J Hepatol. 2019 Sep;71(3):534-542. doi: 10.1016/j.jhep.2019.05.005. Epub 2019 May 18.
7
Liver imaging reporting and data system (LI-RADS) v2018: comparison between computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.肝脏影像报告和数据系统(LI-RADS)v2018:计算机断层扫描与钆塞酸增强磁共振成像的比较。
Jpn J Radiol. 2019 Sep;37(9):651-659. doi: 10.1007/s11604-019-00855-x. Epub 2019 Jul 18.
8
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.肝胆磁共振对比剂摄取作为预测病理侵袭性特征和降低可切除肝细胞癌无复发生存率的生物标志物:与双示踪剂 18F-FDG 和 18F-FCH PET/CT 的比较。
Eur Radiol. 2020 Oct;30(10):5348-5357. doi: 10.1007/s00330-020-06923-5. Epub 2020 May 13.
9
Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.优化钆塞酸二钠增强磁共振成像肝胆期延迟时间,以识别不同严重程度肝硬化患者的肝细胞癌。
World J Gastroenterol. 2018 Jan 21;24(3):415-423. doi: 10.3748/wjg.v24.i3.415.
10
LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.LI-RADS 版本 2017 与版本 2018:钆塞酸二钠增强 MRI 诊断肝细胞癌。
Radiology. 2019 Sep;292(3):655-663. doi: 10.1148/radiol.2019182867. Epub 2019 Jul 16.